Shanghai Yulong Medical Laboratory Co., Ltd.

Yulong Biomedical Group originated in 2002, dedicated to the application of sophisticated molecular biology technology, information technology, automation control technology, and laboratory medicine technology to human health. Always committed to "caring for life and promoting health" and pursuing the establishment of industry standards, after more than a decade of development and growth, adhering to the business philosophy of "continuous innovation and sustainable development," the foundation of today's enterprise has been achieved:
The Group owns national "*" enterprises, the domestic premier "National Engineering Laboratory for Immunodiagnostic Reagents," the precision diagnostics platform - National Gene Testing Technology Application Demonstration Center, National High-Tech Industrialization Demonstration Project, Shanghai High-Tech Enterprise, Shanghai Patent Work Demonstration Enterprise, and Shanghai Intellectual Property Demonstration Enterprise. It has formed three major businesses: "Diagnostic Products," "Medical Laboratory Testing," and "Health Management," constructing the grand blueprint of Yulong Biomedical Group's "Comprehensive Health Industry." It has successively undertaken multiple key national projects including the "863 Major Special Project," holds 218 patented technologies, and has received 109 patent authorizations, ranking at a leading position.
Yulong Biomedical possesses internationally advanced R&D centers and production bases, having established eight modern biotechnology platforms including biochips, automated instruments, bioinformatics, biosensors, genetic engineering, cell engineering, antibody libraries, and protein purification, forming a comprehensive R&D and production system for diagnostic products, raw materials, and supporting instruments. It has independently developed quantitative detection systems for multiple tumor markers in men and women, a series of immunochemiluminescent quantitative detection systems, a series of gene detection systems, LCT liquid-based cytology detection systems, a series of biochemical detection systems, urine detection systems, and CTC liquid biopsy systems. These include the most advanced in vitro precision diagnostic technologies and have received numerous national, provincial, and ministerial awards.
Yulong Medical Laboratory is committed to the clinical application and technological innovation of medical diagnostic technology, having built a comprehensive and systematic diagnostic technology platform, including a national gene testing technology application demonstration center covering prenatal screening, personalized medication, and gene sequencing. It provides accurate and timely diagnostic results and basis for clinical diagnosis of various diseases, strictly managed in accordance with international authoritative standards such as ISO15189 and the US CAP accreditation. It houses Shanghai's first judicial appraisal institute established on the basis of an independent medical laboratory, capable of providing DNA paternity testing and forensic biological evidence appraisal services. In 2014, Yulong Medical Laboratory signed an agreement with the Shanghai Xuhui District Health and Family Planning Commission to jointly build a regional medical laboratory center, establishing a standardized information platform with all district health service centers. Currently, Yulong Medical Laboratory has reached cooperation agreements with governments and health and family planning commissions in Jiangsu, Shandong, Anhui, and other regions, undertaking the overall management of various medical institutions within their jurisdictions to jointly build regional medical laboratory centers, providing internationally advanced medical laboratory services, greatly enhancing the technical level of primary medical laboratory testing, and providing strong support for the implementation of hierarchical diagnosis and treatment.
Yulong Health is dedicated to building the most professional health management service platform domestically, utilizing authoritative Internet+ and Yulong's big data platform to provide personalized health management including: health check-ups, various gene tests, sub-health management, early disease intervention, precision medicine, international medical referral, and green channels for medical treatment, offering one-stop, full-lifecycle private customized services. The Yulong Health platform can provide analysis of items such as doctor work assistants, electronic health records, and insurance data for enterprise and institutional clients, helping medical care institutions and insurance companies improve work efficiency and service quality; simultaneously, the platform provides personalized medical care plans and disease risk assessments for individual clients, helping them shift from a model of overdrawing health and fighting diseases to a new health model of nurturing health and preventing diseases.
With the goal of becoming a leading enterprise in the comprehensive health industry and a business pattern centered on diagnostic products, medical laboratory testing, and health management, the panoramic picture of the complete industrial chain of "Yulong Comprehensive Health" is gradually unfolding.